GENETICALLY MODIFIED HEMATOPOIETIC STEM AND PROGENITOR CELLS (HSPCS) AND MESENCHYMAL CELLS AS A PLATFORM TO REDUCE OR PREVENT METASTASIS, TREAT AUTOIMMUNE AND INFLAMMATORY DISORDERS, AND REBALANCE THE IMMUNE MILIEU AND DYSREGULATED NICHES
Technology
E-053-2019
Patent ID
E-053-2019-0-US-12
Country
US
Application Type
National Stage
Patent Status
Pending
Patent Number
Publication Number
US-2022-0127575-A1
Application Number
17/429,391
IC
NCI
Date Filed
Date Issued
Patent PDF